companydata.dkcompanydata.dk

BIOFAC A/S: Financial statements 2025

CVR: 62550511

Source: annual report 2025, Danish Business Authority

01/07/2024 – 30/06/2025

BIOFAC A/S (CVR 62550511) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 73,647,426 and a net result of DKK -3,775,890 compared with DKK 332,520 the year before. That is an increase of 12.2% compared with the year before. Equity in the 2025 report amounted to DKK 10,810,382. The solvency ratio was 7.2%. The company had 77 employees in the financial year.

Gross Profit
DKK 73,647,426
Profit/Loss
DKK -3,775,890
Equity
DKK 10,810,382
Total Assets
DKK 151,156,248
Employees
77

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-73.6 mio.-3.8 mio.10.8 mio.77
2024-65.7 mio.333 t.14.6 mio.75
2023-37.3 mio.1.6 mio.14.3 mio.73
2022-20.3 mio.-6 mio.12.6 mio.76
2021-28.8 mio.-1.1 mio.18.6 mio.71

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOFAC A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About BIOFAC A/S

BIOFAC A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1934. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Helle Rørvig, Niels Ulrik Heine and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 83 employees (2026). In 2025, the company reported a gross profit of DKK 73,647,426 and a net result of DKK -3,775,890 compared with DKK 332,520 the year before. Equity in the 2025 report amounted to DKK 10,810,382.

Source: annual report 2025, Danish Business Authority